Technology COMPANY VIEW development of Japanese anti-corona agent is probably delayed further

11:05  07 june  2020
11:05  07 june  2020 Source:   pressfrom.com

FIRMEN-BLICK-Wirecard holds on to annual targets despite investigations

 FIRMEN-BLICK-Wirecard holds on to annual targets despite investigations Jun 07 (Reuters) - This is followed by a Reuters look at important developments in the corporate world beyond the top issues of the day: WIRECARD - Frankfurt: The payment processor holds despite investigations into suspected market manipulation are sticking to its annual targets. "The ongoing investigation has no impact on Wirecard AG's operating business," the group said on Sunday. "No significant discrepancies" from the preliminary figures reported are expected.

Some companies have expressed optimism that governments will curb new infections and that consumer spending in Europe and North America will be largely The stock-market plunge this week, the steepest since the financial crisis, suggests that investors are bracing for a lot more bad news.

That said, today I’m highlighting 50 helpers. When the pressure is on, and governments are overloaded, it is up to businesses large and small to do things that will better their employees, customers and the community at large, until this difficult time passes.

Jun 07 (Reuters) - The Reuters view on important developments in the corporate world follows beyond the top issues of the day:

FUJIFILM - Tokyo : The Japanese company faces additional hurdles in the search for a drug against the new coronavirus. The development of the Avigan agent is likely to be delayed further. A company spokesman confirmed that the clinical trials could drag on into July. The reason for this is according to the business newspaper "Nikkei" that the researchers have so far only had 70 percent of the required test patients. The Japanese government has high hopes for Avigan, also known as favipiravir. After approval failed in May, the clinical studies should be completed in June according to previous plans. (Compiled in the editorial offices in Berlin, Frankfurt, Gdansk, Zurich and Vienna. If you have any questions, please contact the editorial team on +49 69 7565 1232 or +49 30 2888 5168.)

recovery on Wall Street: Dow Jones crosses the 24,000-point mark .
After the inconsistent price development on Wednesday, the US stock markets showed a strong recovery on Thursday. © Provided by Finanz.net GmbH DANIEL ROLAND / AFP / Getty Images The Dow Jones started the trading day 0.73 percent firmer at 23,837.21 points. In the further course, the stock market barometer expands the spreads even further and breaks the 24,000 mark. The Dow currently shows an increase of 1.46 percent to 24,009.38 units.

—   Share news in the SOC. Networks
usr: 0
This is interesting!